Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function.
Citation: International Journal of Cardiology. 169(5):e84-6, 2013 Nov 20.PMID: 24377111Institution: MedStar Washington Hospital CenterDepartment: Medicine/General Internal MedicineForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *Anti-Arrhythmia Agents/tu [Therapeutic Use] | *Atrial Fibrillation/dt [Drug Therapy] | *Digoxin/tu [Therapeutic Use] | *Severity of Illness Index | *Ventricular Dysfunction, Left/dt [Drug Therapy] | Aged | Atrial Fibrillation/pp [Physiopathology] | Female | Follow-Up Studies | Humans | Male | Middle Aged | Retrospective Studies | Ventricular Dysfunction, Left/pp [Physiopathology]Year: 2013ISSN:- 0167-5273
| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Journal Article | MedStar Authors Catalog | Article | 24377111 | Available | 24377111 |
English